Abstract
purpose. To study matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the corneas from mice with ulcerative herpes stromal keratitis (HSK) treated with amniotic membrane transplantation (AMT).
methods. The corneas from BALB/c mice were infected with HSV-1. Mice with ulcerative HSK on postinfection (PI) day 14 were used for the experiments. In one group of mice, the corneas were treated with transplantation of amniotic membrane (AMT) that was secured with a tarsorrhaphy, and a control group underwent tarsorrhaphy alone. After 2 days, the appearance of corneal ulcers and stromal inflammation was judged clinically. Corneal sections were studied by immunohistochemistry for the expression of MMP-2, -8, and -9 and TIMP-1 and -2. MMP activity in the corneas was investigated by zymography, and the expression of the enzymes was measured by the Western blot technique.
results. At day 14 PI, the ulcers stained intensely positive for MMP-2, -8, and -9 and TIMP-1 and -2. Ulceration (P < 0.001), stromal inflammation (P < 0.01) and inflammatory cell infiltration (P < 0.001) markedly improved by day 2 after AMT. This was associated with reduced expression (P < 0.01) and activity of MMP-8, and -9 and increased localization of TIMP-1 (P < 0.01), whereas TIMP-2 was not affected. In contrast, high levels of expression of MMP-8 and -9 remained in the cornea after tarsorrhaphy, and the TIMP-1 expression was only slightly upregulated.
conclusions. Rapid improvement of HSV-1-induced ulcerative keratitis is noted after amniotic membrane transplantation. This may be caused by reduced expression and activity of MMP-8 and -9, increased expression of TIMP-1, and sustained expression of TIMP-2.
An HSV-1 infection of the cornea may induce a severe inflammatory disease that is termed herpetic stromal keratitis (HSK). The corneal lesion is not caused primarily by viral replication, but by immune responses directed against the viral components. CD4
+ Th1 lymphocytes play a key role in the initiation of the disease.
1 2 Polymorphonuclear cells (PMNs) are the most prominent cells during development of the inflammation and are involved in the destruction of the corneal architecture.
3 4 Recent experiments suggest that the proinflammatory cytokines interleukin IL-1 and TNF-α play major roles in the pathogenesis of HSK.
5 6 7
The amniotic membrane (AM) is the innermost layer of the fetal membrane, comprising a thick, continuous basement membrane and an avascular stroma.
8 AMs suitable for transplantation can be obtained shortly after elective cesarean delivery.
9 In recent years, several anti-inflammatory effects from AMs have been described (Bültmann S, et al.
IOVS 1999;40:ARVO Abstract 3044).
9 10 11 12 13 14 15 16 Most recently, it has been shown that ulcerating necrotizing HSK rapidly improves after amniotic membrane transplantation (AMT).
17 18
Metalloproteinases (MMPs) are a family of proteolytic enzymes that are capable of degrading the extracellular matrix and basement membrane components. In general, MMPs are released as proenzymes and are activated by proteolytic cleavage of the N-terminal region. Tissue inhibitors of metalloproteinases (TIMPs) are the most important endogenous regulators of MMP activity.
19 20 21 MMPs participate in tissue remodeling and also play an important role in corneal scarring. Previously, it has been shown that MMP-9, a considerable amount of which is produced by neutrophils, participates in the development of HSK and corneal ulcer.
22 23
Natural inhibitors of various MMPs have been found in AMs.
12 24 We therefore investigated whether AMT in experimental HSK would change the expression and activity of MMPs and their inhibitors in the HSV-1-infected cornea. We found that the AMT induced a strong improvement of the HSK and that the improvement was associated with reduced expression and activity of MMP-2, -8, and -9. The expression of TIMP-1 was increased, whereas TIMP-2 remained at the same expression level.
To investigate the effect of AMT on corneal cytokine production, the corneas were excised from the globes, and the conjunctiva and iris were removed. Samples were stored at −80°C until assayed. The corneas were thawed, minced, and sonicated for 30 seconds, and the supernatant was clarified by centrifugation at 10,000g for 10 minutes. The tissue homogenates were assayed for IL-1α, and TNF-α with the use of commercially available enzyme-linked immunosorbent assay (ELISA) kits (BD Biosciences, Heidelberg, Germany).
Localization of MMP-2, -8, and -9 and TIMP-1 and -2 in Tarsorrhaphy- and AMT-Treated Corneas with Ulcerative HSK
Expression of MMPs and TIMPs after AMT or Tarsorrhaphy and in Corneas with Severe HSK
Gelatinolytic and Caseinolytic Activities of Soluble Corneal Proteins after AMT or Tarsorrhaphy
Levels of IL-1α and TNF-α in the HSV-1-Infected Corneas 2 Days after AMT or Tarsorrhaphy
Destruction of the extracellular matrix in the cornea is closely related to the increased activity of metalloproteinases.
30 MMPs are expressed by the corneal epithelial cells and keratocytes, but also by infiltrating PMNs and macrophages. Activated PMNs are able to secrete MMPs from their granules.
31 32 We have shown
23 that the expression and activity of gelatinases (MMP-2 and -9) and collagenase (MMP-8) are upregulated in the corneas of mice with ulcerating necrotizing keratitis.
Recently, it has been shown that the severity of ulcerating HSK and the number of inflammatory cells in the cornea significantly decrease after AMT in HSV-1-infected BALB/c mice.
17 The underlying T-cell-mediated immune disease may recur during the subsequent follow-up after removal of the membrane or after its dissolution. Local effects were suggested to be primarily responsible for the improvement.
18
Our immunohistochemical studies of HSV-infected corneas treated with AMT for 2 days revealed that the expression of MMP-8 and -9 was markedly reduced in corneal epithelium and keratocytes. It was also evident that the total number of inflammatory cells and the PMNs that stained positively with the respective MMP antibodies were significantly reduced after AMT, compared with the control group of mice that underwent a tarsorrhaphy. The reduction of the MMP-2 expression in the cornea after AMT was less pronounced.
These findings are supported by the Western blot analysis, showing that AMT was followed by a decrease in MMP-8 and -9 expression in the corneas. Furthermore, the zymographic investigation of the corneas disclosed that the enzymatic activities of MMP-8 and -9 were reduced after AMT. In contrast, the MMP-2 expression and gelatinolytic activity was only slightly reduced in the corneas at 2 days after AMT, but was apparent at 7 days after AMT (data not shown). Taken together, these findings suggest that the improvement of inflammation in the HSV-1 infected cornea after AMT may result in part from reduced expression and activity of MMP-8 and -9, especially in the infiltrating inflammatory cells.
There are several physiological mechanisms that control MMP expression and activity. MMP activity is critically regulated by TIMP.
33 The proenzyme of MMP is bound and inactivated by the TIMP that is present in tissue. The balance between proteases and TIMP is critical for enzymatic activity.
AM itself has some components that are capable of inhibiting proteinases. Recently, TIMP-1 and -2 were identified in AM.
24 34 The expression of TIMP-1 to -4 was presented on the freshly prepared and the cryopreserved membranes
12 used in our experiments.
In our experiments, the immunohistochemical and Western blot techniques detected that TIMP-1 expression was increased in the HSV-1-infected corneas after AMT. The level of TIMP-2, which is expressed constitutively in tissue,
23 35 36 was not altered after the AM treatment. The decreased MMP activity found in corneal tissue after AMT may have resulted from TIMP-1 and -2. Amniotic membrane patches also inhibited proteinase activity in a rabbit model of acute cornea alkali burn.
24 It has also been shown that MMP-2 and -9 are suppressed in human corneal epithelium and fibroblasts cocultured with an AM extract (Kim JC, et al.
IOVS 2000;41:ARVO Abstract 1393; Park GS, et al.
IOVS 2001;44:ARVO Abstract 3083).
24
Recently, it has been shown that MMP-9 is involved in the corneal angiogenesis caused by HSV-1 infection.
22 The development of stromal keratitis was greatly improved when MMP-9 activity was inhibited by topical administration of TIMP-1 plasmid DNA or when the MMP-9 gene was genetically knocked out in the mice. Of note, the regression of corneal neovascularization we noted in HSV-1-infected mice after AMT
17 also correlated with downregulation of MMP-9 expression and activity and upregulation of TIMP-1 expression.
The expression and secretion of many MMPs are regulated by various proinflammatory cytokines (e.g., IL-1 and TNF-α
36 37 38 39 ). IL-1 and TNF-α are upregulated in corneas from mice with recurrent HSK, whereas treatment with anti-cytokine antibodies abrogates the keratitis.
5 The TNF-α is essentially released from PMNs and macrophages.
39 Transgenic mice that overexpressed the IL-1 receptor antagonist (IL-1ra) protein were more resistant to HSK than were IL-1ra knockout mice, and mice receiving IL-1ra had less severe HSK and corneal inflammatory cell infiltration.
6 7
In our results, high levels of TNF-α and IL-1 were detected in the corneas of HSV-1-infected mice 2 days after tarsorrhaphy, whereas the levels of IL-1α and TNF-α were significantly reduced 2 days after AMT. It has been shown that IL-1 and TNF-α increase the expression of some of the MMP, including MMP-9, in a dose-dependent manner.
38 40 It has also been shown that the expression of IL-1 in corneal epithelial cells is markedly suppressed by AM.
15 It may be speculated that the decreased MMP-9 expression and activity in the HSV-1 infected cornea after AMT is caused by the reduced expression of TNF-α and IL-1.
Taken together, the results show that the improvement in HSK after AMT may be attributable to the reduced expression of IL-1 or TNF-α or indirectly to the cytokine-regulated downregulation of MMP expression. As the IL-1 receptor antagonist was recently detected in both epithelial and mesenchymal cells of AM,
10 this may be another reason for the reduced MMP expression observed in HSV-1-infected corneas after AMT.
Interleukin-10, which is capable of reducing the severity of HSK in mice,
40 41 was also found in AM.
12 This cytokine has been reported to promote the production of TIMP-1 and suppress the expression of MMP.
42 However, no studies are available yet to define the action mechanism of IL-10 in the course of HSK after AMT.
In conclusion, our observations show that AMT modulates the expression and activity of collagenases (especially MMP-9) and of a caseinase (MMP-8) in the HSV-1-infected mouse cornea. This correlates with the upregulation of TIMP-1 and the sustained high expression of TIMP-2, two well-known inactivators of MMPs. Our findings suggest that proinflammatory cytokines are involved in the differential regulation of MMP expression and activity after AMT. The action mechanisms by which MMP and TIMP are influenced after AMT remain to be defined.
Supported by Deutsche Forschungsgemeinschaft (DFG) Grant He-1877/12-1.
Submitted for publication February 13, 2005; revised June 22, 2005; accepted September 21, 2005.
Disclosure:
A. Heiligenhaus, None;
H. Li, None;
Y. Yang, None;
S. Wasmuth, None;
K.P. Steuhl, None;
D. Bauer, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Arnd Heiligenhaus, Department of Ophthalmology, Ophtha-Lab at St. Franziskus Hospital, Hohenzollernring 74, 48145 Münster, Germany;
[email protected].
Table 1. Influence of AMT on the Course of Ulcerative Necrotizing HSK
Table 1. Influence of AMT on the Course of Ulcerative Necrotizing HSK
| Day 14 after HSV | 2 Days after T | 2 Days after AMT |
Severity score of stromal keratitis* | 4.0 ± 0.0 | 3.1 ± 1.1 | 1.2 ± 0.8, ‡ |
Presence of corneal ulceration (n)* | 12 | 10 | 1, § |
Total no. of inflammatory cells in central cornea (n), † | 498.5 ± 64.2 | 434.0 ± 76.6 | 146.2 ± 22.8, § |
PMNs in the central cornea (n), † | 342.9 ± 32.7 | 309.8 ± 42.9 | 122.2 ± 14.3, ‡ |
Table 2. Number of Infiltrating Inflammatory Cells in the Central Cornea with Positive Staining for MMPs and TIMPs
Table 2. Number of Infiltrating Inflammatory Cells in the Central Cornea with Positive Staining for MMPs and TIMPs
| Group | Positively Stained Inflammatory Cells | Positively Stained PMNs |
MMP-2 | Day 14 | 135.4 ± 25.9 | 102.1 ± 39.8 |
| T | 110.8 ± 24.6 | 91.3 ± 37.2 |
| AMT | 75.7 ± 28.4* | 62.1 ± 20.7* |
MMP-8 | Day 14 | 247.3 ± 46.1 | 199.8 ± 23.7 |
| T | 229.4 ± 29.1 | 175.4 ± 12.2 |
| AMT | 92.6 ± 21.2, † | 83.3 ± 19.8, † |
MMP-9 | Day 14 | 245.7 ± 49.5 | 223.3 ± 51.6 |
| T | 225.0 ± 30.9 | 194.6 ± 31.0 |
| AMT | 80.4 ± 15.1, † | 68.2 ± 12.9, † |
TIMP-1 | Day 14 | 89 ± 39.0 | 58.8 ± 38.4 |
| T | 68.0 ± 31.4 | 51.2 ± 23.1 |
| AMT | 106.0 ± 20.4, † | 92.6 ± 12.9, † |
TIMP-2 | Day 14 | 239.2 ± 23.1 | 188.8 ± 12.9 |
| T | 225 ± 15.3 | 194.6 ± 17.3 |
| AMT | 80.4 ± 15.9 | 68.2 ± 14.5 |
HendricksRL, TumpeyTM, FinneganA. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol. 1992;149:3023–3028.
[PubMed]TangQ, ChenW, HendricksRL. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol. 1997;158:1275–1283.
[PubMed]TumpeyTM, ChenSH, OakesJE, LauschRN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type-1 infection of the murine cornea. J Virol. 1996;70:898–904.
[PubMed]ThomasJ, GangappaS, KanangatS, RouseBT. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol. 1997;158:1383–1391.
[PubMed]KeadleTL, UsuiN, LaycockKA, MillerJK, PeposeJS, StuartPM. IL-1 and TNF-a are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 2000;41:96–102.
[PubMed]BiswasPS, BanerjeeK, KimB, RouseBT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol. 2004;172:3736–3744.
[CrossRef] [PubMed]BiswasPS, BanerjeeK, ZhengM, RouseBT. Counteracting corneal immunoinflammatory lesions with interleukin-1 receptor antagonist protein. J Leukoc Biol. 2004;76:868–875.
[CrossRef] [PubMed]FukadaK, ChikamaT, NakamuraM, NishidaT. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73–79.
[CrossRef] [PubMed]LeeS, TsengSCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303–312.
[CrossRef] [PubMed]FidelPL, RomeroR, RamirezM, et al. Interleukin-1 receptor antagonist (IL-1ra) production by human amnion, chorion, and decidua. Am J Reprod Immunol. 1994;32:1–7.
[CrossRef] [PubMed]HanadaK, ShimazakiJ, ShimmuraS, TsubotaK. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol. 2001;131:324–331.
[CrossRef] [PubMed]HaoY, Hui-KangD, HwangDG, KimWS, ZhangF. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19:348–352.
[CrossRef] [PubMed]ParkWC, TsengSC. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci. 2000;41:2906–2914.
[PubMed]ShimmuraS, ShimazakiJ, OhashiY, TsubotaK. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408–413.
[CrossRef] [PubMed]SolomonA, RosenblattM, MonroyD, JiZ, PflugfelderSC, TsengSC. Suppression of interleukin 1 alpha and interleukin 1 beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol. 2001;85:444–449.
[CrossRef] [PubMed]UetaM, KweonMN, SanoY, et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol. 2002;129:464–470.
[CrossRef] [PubMed]HeiligenhausA, BauerD, MellerD, SteuhlKP, TsengSC. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42:1969–1974.
[PubMed]HeiligenhausA, BauerD, WasmuthS, SteuhlKP. Amniotic membrane transplantation improves herpetic keratitis by local and not by systemic effects (in German). Ophthalmologe. 2003;100:209–215.
[CrossRef] [PubMed]MatrisianLM. Metalloproteinases and their inhibitors in matrix remodeling. Trend Genet. 1990;6:121–125.
[CrossRef] DasSK, YanoS, WangJ, EdwardsDR, NagaseH, DeySK. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev Genet. 1997;21:44–54.
[CrossRef] [PubMed]GomezDE, AlonsoDF, YoshijiH, ThorgeirssonUP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111–122.
[PubMed]LeeS, ZhengM, KimB, RouseBT. Role of metalloproteinase-9 in angiogenesis caused be ocular infection with herpes simplex virus. J Clin Invest. 2002;110:1105–1111.
[CrossRef] [PubMed]YangYN, BauerD, WasmuthS, SteuhlKP, HeiligenhausA. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res. 2003;77:227–237.
[CrossRef] [PubMed]KimJS, KimJC, NaBK, JeongJM, SongCY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70:329–337.
[CrossRef] [PubMed]BauerD, MrzykS, van RooijenN, SteuhlKP, HeiligenhausA. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res. 2000;20:45–53.
[CrossRef] [PubMed]HeiligenhausA, BauerD, ZhengM, MrzykS, SteuhlKP. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol. 1999;237:399–406.
[CrossRef] [PubMed]GirardMT, MatsubaraM, FiniME. Transforming growth factor beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441–2454.
[PubMed]Bevans-NelsonSE, LauschRN, OakesJE. Tumour necrosis factor-alpha and not interleukin-1 alpha is the dominant inducer of matrix metalloproteinase-9 synthesis in human corneal cells. Exp Eye Res. 2001;73:403–407.
[CrossRef] [PubMed]HaoJL, NaganoT, NakamuraM, KumagaiN, MishimaH, NishidaT. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases. Exp Eye Res. 1999;68:565–572.
[CrossRef] [PubMed]FiniME, CookJR, MohanR. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290:12–23.
[CrossRef] TriebelS, BlaserJ, GoteT, et al. Evidence for the tissue of inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. Eur J Biochem. 1995;231:714–719.
[CrossRef] [PubMed]Trinkaus-RandallV, LeibowitzHM, RyanWJ, KupfermanA. Quantification of stromal destruction in inflamed cornea. Invest Ophthalmol Vis Sci. 1991;32:603–609.
[PubMed]BrewK, DinakarpandianD, NagaseH. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267–283.
[CrossRef] [PubMed]FortunatoSJ, MenonR, LombardiSJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol. 1997;177:731–741.
[CrossRef] [PubMed]De ClerckYA, DarvilleMI, EeckhoutY, RousseauGG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinase-2 (TIMP-2). Gene. 1994;139:185–191.
[CrossRef] [PubMed]RiesC, PetridesPE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Bio Chem Hoppe Seyler. 1995;376:345–355.
PostlethwaiteAE, LachmanLB, MainardiCL, KangAH. Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med. 1983;157:801–806.
[CrossRef] [PubMed]LiDP, LokeshwarBL, SolomonA, MonroyD, JiZ, PflugfelderSC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449–459.
[CrossRef] [PubMed]DaheshiaM, KanangatS, RouseBT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res. 1998;67:619–624.
[CrossRef] [PubMed]Li deQ, ShangTY, KimHS, SolomonA, LokeshwarBL, PflugfelderSC. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:2928–2936.
[CrossRef] [PubMed]TumpeyTM, ElnerVM, ChenSH, OakesJE, LauschRN. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol. 1994;153:2258–2265.
[PubMed]LacrazS, NicodLP, ChicheporticheR, WelgusHG, DayerJM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995;96:2304–2310.
[CrossRef] [PubMed]